Charles Schwab Investment Management Inc Harpoon Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $77,193 - $217,702	-43,367 Reduced 80.92%	10,228 $20,000
Q1 2022 May 13, 2022	BUY	$3.54 - $8.08 $13,161 - $30,041	3,718 Added 7.45%	53,595 $267,000
Q3 2021 Nov 16, 2021	SELL	$7.88 - $14.0 $971,013 - $1.73 Million	-123,225 Reduced 71.19%	49,877 $395,000
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $230,944 - $388,809	16,723 Added 10.69%	173,102 $2.4 Million
Q1 2021 May 17, 2021	BUY	$17.65 - $24.16 $713,342 - $976,450	40,416 Added 34.85%	156,379 $3.27 Million
Q4 2020 Feb 16, 2021	BUY	$12.83 - $17.84 $89,130 - $123,934	6,947 Added 6.37%	115,963 $1.93 Million
Q3 2020 Nov 13, 2020	BUY	$11.01 - $18.52 $415,671 - $699,204	37,754 Added 52.98%	109,016 $1.85 Million
Q2 2020 Aug 14, 2020	BUY	$11.11 - $24.72 $283,549 - $630,903	25,522 Added 55.8%	71,262 $1.18 Million
Q1 2020 May 15, 2020	BUY	$10.74 - $16.32 $6,239 - $9,481	581 Added 1.29%	45,740 $530,000
Q4 2019 Feb 07, 2020	BUY	$12.94 - $20.58 $5,641 - $8,972	436 Added 0.97%	45,159 $668,000
Q3 2019 Nov 08, 2019	BUY	$10.93 - $17.47 $80,051 - $127,950	7,324 Added 19.58%	44,723 $611,000
Q2 2019 Aug 09, 2019	BUY	$10.0 - $13.03 $72,320 - $94,232	7,232 Added 23.97%	37,399 $487,000
Q1 2019 May 14, 2019	BUY	$9.47 - $17.01 $285,681 - $513,140	30,167 New	30,167 $286,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.